Main Logo
Roundtable: DLBCL

Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
In this DLBCL roundtable, experts share which novel agents or combinations they are most interested in.
View More
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
Ruemu Birhiray, MD, leads an expert roundtable on the current treatment pathway in DLBCL.
Ruemu Birhiray, MDAggressive B-Cell Lymphoma | March 10, 2025
The expert panel assesses the current and expected utility for clinicians of MRD in DLBCL management decisions.